Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-19

Clinical Trial Update: A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients [Phase 1]

View source ↗

Summary

This completed Phase 1 clinical trial evaluated the pharmacokinetics and tolerability of a single dose of trientine dihydrochloride in patients with Wilson's di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trientine Dihydrochloride (trientine dihydrochloride)

Snippet

Sponsor: Univar BV | Conditions: Wilson's Disease | Phase 1 | Status: COMPLETED